Acta Scientific Dental Sciences (ISSN: 2581-4893)

Research Article Volume 4 Issue 12

Inflammatory Pathology of the Oral Cavity: Relevance in Oral Oncogenesis

Teresa Sequeira1,2*, Gonçalo Sousa1, Eurico Monteiro1,3 and Augusta Silveira1,2

1Fernando Pessoa University – Health Sciences Faculty, Porto, Portugal
2Center for Health Studies and Research of the University of Coimbra and Center for Innovation in Biomedicine and Biotechnology, Coimbra, Portugal
3Portuguese Oncology Institute - Porto, Portugal

*Corresponding Author: Teresa Sequeira, Associate Professor, Researcher, Fernando Pessoa University – Health Sciences Faculty (UFP-FCS), Portugal.

Received: October 22, 2020; Published: November 30, 2020



  Oral cancer is considered to be a growing public health problem and within head and neck cancer pathology, it is the most common. It is the 6th most common cancer in the world, corresponding to approximately 3% of all cancers.

  Despite the dedication and investment in this pathology, the advances in diagnosis strategies and the development of early intervention programs and treatments, aimed to be more targeted, more effective and less aggressive, the global survival rate after 5 years has remained worldwide at approximately 50% over the last three decades. The evaluation of Quality of Life stands out in this context as a key indicator, along with survival.

  We aim to review oral cancer etiology and discuss inflammation role in oral oncogenesis, considering its potential to modulate and amplify the impact of known risk factors. Additionally, we point out inflammation as predictive of poor prognosis in patients with oral cancer or at risk of developing it.

  Articles were collected from the PubMed, Bon, Elsevier, Science Direct databases, considering mainly the last 5 years of publication (2015 to 2020). The indexing terms used were "oral oncology and risk factors", "oral oncology and epidemiology" and "inflammation and oncogenesis".

  The role of the immune system and inflammation in the initiation, promotion and progression of oncologic pathology of the oral cavity has deserved maximum attention from the scientific community. It is clear that the presence of pro-inflammatory factors associated with immunosuppression are closely related to oral oncogenesis and poor prognosis. The chronic inflammation can contribute to modulate and amplify risk factors actions.

  Chronic inflammatory pathology and microbioma of the oral cavity have relevance in oral oncology and can be used as biomarkers, signaling patients at higher risk. There is a whole potential knowledge that can contribute to a better understanding of oral oncogenesis and therefore making it easier both to identify individuals at risk and to achieve more targeted and focused treatment strategies for each cancer patient.

Keywords: Oral Cancer; Risk Factors; Etiology; Quality of Life; Inflammation; Prognosis



  1. Kahriman Fatma and Ayten Zaybak. “Caregiver Burden and Perceived Social Support among Caregivers of Patients with Cancer”. Asian Pacific Journal of Cancer Prevention: APJCP8 (2015): 3313-3317.
  2. Kassianos Angelos P., et al. “The impact of specialized palliative care on cancer patients' health-related quality of life: a systematic review and meta-analysis”. Supportive Care in Cancer: official Journal of the Multinational Association of Supportive Care in Cancer1 (2018): 61-79.
  3. Ren Zhen-Hu., et al. “Global and regional burdens of oral cancer from 1990 to 2017: Results from the global burden of disease study”. Cancer Communications (London, England)2-3 (2020): 81-92.
  4. Schwingshackl Lukas., et al. “Adherence to Mediterranean Diet and Risk of Cancer: An Updated Systematic Review and Meta-Analysis”. Nutrients10 (2017).
  5. Silveira Augusta., et al. “Head and Neck Cancer: Improving Patient-Reported Outcome Measures for Clinical Practice”. Current Treatment Options in Oncology11 (2018): 59.
  6. Lewandowska Anna Maria., et al. “Environmental risk factors for cancer - review paper”. Annals of Agricultural and Environmental Medicine: AAEM1 (2019): 1-7.
  7. Mattiuzzi Camilla and Giuseppe Lippi. “Current Cancer Epidemiology”. Journal of Epidemiology and Global Health 4 (2019): 217-222.
  8. Epstein Joel B and Pelin Güneri. “The adjunctive role of toluidine blue in detection of oral premalignant and malignant lesions”. Current Opinion in Otolaryngology and Head and Neck Surgery2 (2009): 79-87.
  9. Sequeira, Teresa., et al. “10-Year Experience: Routine Assessment of Health-Related Quality of Life in Head and Neck Cancer Patients”. Global Journal of Otolaryngology 2 (2017).
  10. Ghantous Yasmine and Imad Abu Elnaaj. “Global incidence and risk factors of oral cancer”. Harefuah 10 (2017): 645-649.
  11. Siegel Rebecca L., et al. “Cancer statistics, 2020”. CA: a Cancer Journal for Clinicians1 (2020): 7-30.
  12. Ferlay Jacques., et al. “Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012”. International Journal of Cancer 5 (2015): E359-386.
  13. World Health Organization.
  14. Hsiao Jenn-Ren., et al. “The interplay between oral microbiome, lifestyle factors and genetic polymorphisms in the risk of oral squamous cell carcinoma”. Carcinogenesis6 (2018): 778-787.
  15. Li Zhen-Ning., et al. “The p38/MKP-1 signaling axis in oral cancer: Impact of tumor-associated macrophages”. Oral Oncology 103 (2020): 104591.
  16. Varshney PK., et al. “Tobacco and alcohol consumption in relation to oral cancer”. Indian Journal of Otolaryngology and Head and Neck Surgery: Official Publication of the Association of Otolaryngologists of India1 (2003): 25-28.
  17. Patel K R., et al. “Clinical implications of p53 alterations in oral cancer progression: a review from India”. Experimental Oncology1 (2018): 10-18.
  18. Chaturvedi Pankaj., et al. “Tobacco related oral cancer”. BMJ (Clinical research ed.) 365 (2019).
  19. GBD 2016 Alcohol Collaborators. “Alcohol use and burden for 195 countries and territories, 1990– 2016: a systematic analysis for the Global Burden of Disease Study 2016”. Lancet 392 (2018): 1015-1035.
  20. Kawakita Daisuke and Keitaro Matsuo. “Alcohol and head and neck cancer”. Cancer Metastasis Reviews 3 (2017): 425-434.
  21. Varoni Elena M., et al. “Ethanol versus Phytochemicals in Wine: Oral Cancer Risk in a Light Drinking Perspective”. International Journal of Molecular Sciences 8 (2015): 17029-17047.
  22. Pöschl G and H K Seitz. “Alcohol and cancer”. Alcohol and Alcoholism (Oxford, Oxfordshire)3 (2004): 155-165.
  23. Korzeniewski Nina., et al. “Genomic instability and cancer: lessons learned from human papillomaviruses”. Cancer Letters2 (2011): 113-122.
  24. Asthana Smita., et al. “Association of smokeless tobacco with oral cancer: A review of systematic reviews”. Tobacco Prevention and Cessation 5 (2019): 34.
  25. Newman Taylor M.., et al. “Microbiomic differences at cancer-prone oral mucosa sites with marijuana usage”. Scientific Report 9 (2019): 12697.
  26. Ortiz Ana P., et al. “Association of marijuana use with oral HPV infection and periodontitis among Hispanic adults: Implications for oral cancer prevention”. Journal of Periodontology5 (2018): 540-548.
  27. Guidry J T., et al. “Epstein-Barr virus in the pathogenesis of oral cancers”. Oral Diseases4 (2018): 497-508.
  28. Silva Joaquim Castro., et al. “Head and Neck Cancer Early Identification of Malnutrition High Risk Patients and Quality of Life Optimization”. International Journal of Otolaryngology and Head and Neck Surgery 8 (2019): 204-216.
  29. Shivappa Nitin., et al. “Inflammatory potential of diet and risk of oral and pharyngeal cancer in a large case-control study from Italy”. International Journal of Cancer3 (2017): 471-479.
  30. Net. [Online].
  31. Awan Kamran Habib., et al. “Oral and pharyngeal cancer risk associated with occupational carcinogenic substances: Systematic review”. Head and Neck12 (2018): 2724-2732.
  32. Richardson David B., et al. “Site-specific Solid Cancer Mortality After Exposure to Ionizing Radiation: A Cohort Study of Workers (INWORKS)”. Epidemiology (Cambridge, Mass.)1 (2018): 31-40.
  33. Zhang Yangheng., et al. “Human oral microbiota and its modulation for oral health”. Biomedicine and Pharmacotherapy = Biomedecine and Pharmacotherapie 99 (2018): 883-893.
  34. Zhao Hongsen., et al. “Variations in oral microbiota associated with oral cancer”. Scientific Reports1 (2017): 11773.
  35. Karmakar Shaswata., et al. “Periodontitis and oral Cancer-A striking link”. Oral Oncology 106 (2020): 104630.
  36. Ali Johar., et al. “Genetic etiology of oral cancer”. Oral Oncology 70 (2017): 23-28.
  37. Huang,Y., et al. “Identification of novel genetic variants predisposing to familial oral squamous cell carcinomas”. Cell Discovery 5 (2019): 57.
  38. Al-Kaabi Rasha., et al. “Social inequalities in oral cancer literacy in an adult population in a multicultural deprived area of the UK”. Journal of Public Health3 (2015).
  39. Singh Nitin., et al. “Inflammation and cancer”. Annals of African Medicine3 (2019): 121-126.
  40. Kim Jaehong and Jong-Sup Bae. “Tumor-Associated Macrophages and Neutrophils in Tumor Microenvironment”. Mediators of Inflammation 2016 (2016): 6058147.
  41. Xiao Meng., et al. “M1-like tumor-associated macrophages activated by exosome-transferred THBS1 promote malignant migration in oral squamous cell carcinoma”. Journal of Experimental and Clinical Cancer Research: CR1 (2018): 143.
  42. Vergara Daniele., et al. “The Cancer Microbiota: EMT and Inflammation as Shared Molecular Mechanisms Associated with Plasticity and Progression”. Journal of Oncology (2019): 1253727.
  43. Peltanova B., et al. “Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review”. Molecular Cancer63 (2019): 1-24.
  44. Van Overmeire Eva., et al. “Mechanisms driving macrophage diversity and specialization in distinct tumor microenvironments and parallelisms with other tissues”. Frontiers in Immunology 5 (2014): 127.
  45. Sousa S., et al. “Human breast cancer cells educate macrophages toward the M2 activation status”. Breast Cancer Research: BCR 17 (2015): 101.
  46. Coussens Lisa M and Zena Werb. “Inflammation and cancer”. Nature 6917 (2002): 860-867.
  47. Schmieder Astrid., et al. “Differentiation and gene expression profile of tumor-associated macrophages”. Seminars in Cancer Biology4 (2012): 289-297.
  48. Rijkschroeff Patrick., et al. “Oral polymorphonuclear neutrophil characteristics in relation to oral health: a cross-sectional, observational clinical study”. International Journal of Oral Science 3 (2019): 191-198.
  49. Amulic Borko., et al. “Neutrophil function: from mechanisms to disease”. Annual Review of Immunology 30 (2012): 459-489.
  50. Silvestre-Roig Carlos., et al. “Neutrophil heterogeneity: implications for homeostasis and pathogenesis”. Blood 18 (2016): 2173-2181.
  51. Leliefeld Pieter HC., et al. “Differential antibacterial control by neutrophil subsets”. Blood Advances11 (2018): 1344-1355.
  52. Hellebrekers Pien., et al. “Neutrophil phenotypes in health and disease”. European Journal of Clinical Investigation 2 (2018): e12943.
  53. Rijkschroeff Patrick., et al. “Oral Polymorphonuclear Neutrophil Contributes to Oral Health”. Current oral Health Reports4 (2018): 211-220.
  54. Dutra Kamile Leonardi., et al. “Incidence of reactive hyperplastic lesions in the oral cavity: a 10 year retrospective study in Santa Catarina, Brazil”. Brazilian Journal of Otorhinolaryngology4 (2019): 399-407.
  55. Melo Auremir Rocha., et al. “Prevalência de lesões bucais diagnosticadas no laboratório de patologia bucal da Universidade Tiradentes (2002-2010)/Prevalence of oral lesions diagnosed in oral pathology laboratory of Tiradentes University (2002-2010)”. Revista de Cirurgia e Traumatologia Buco-maxilo-facial 2 (2013): 109-114.
  56. Vidyanath Surendran., et al. “Reactive hyperplasic lesions of the oral cavity: A survey of 295 cases at a Tertiary Health Institution in Kerala”. Journal of Oral and Maxillofacial Pathology: JOMFP3 (2015): 330-334.
  57. Kashyap Bina., et al. “Reactive lesions of oral cavity: A survey of 100 cases in Eluru, West Godavari district”. Contemporary Clinical Dentistry3 (2012): 294-297.
  58. Karpiński Tomasz M. “Role of Oral Microbiota in Cancer Development”. Microorganisms 7.1 (2019): 20.
  59. Murata Mariko. “Inflammation and cancer”. Environmental Health and Preventive Medicine1 (2018): 50.
  60. Zhang Wei-long., et al. ” Who Is Who in Oral Cancer?” Experimental Cell Research 384 (2019): 111634.
  61. Sakamoto, Haruo., et al. “Isolation of bacteria from cervical lymph nodes in patients with oral cancer”. Archives of Oral Biology10 (1999): 789-793.
  62. Katz Joseph., et al. “Presence of Porphyromonas gingivalis in gingival squamous cell carcinoma”. International Journal of Oral Science4 (2011): 209-215.
  63. Scheff Nicole N., et al. “Tumor necrosis factor alpha secreted from oral squamous cell carcinoma contributes to cancer pain and associated inflammation”. Pain12 (2017): 2396-2409.


Citation: Teresa Sequeira., et al. “Inflammatory Pathology of the Oral Cavity: Relevance in Oral Oncogenesis". Acta Scientific Dental Sciences 4.12 (2020): 120-129.


Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.278

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 30, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US